New cancer clinical trial: Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer

Published on: March 27, 2018 at 12:00PM
Condition:   Prostate Cancer
Interventions:   Drug: Enzalutamide Liquid;   Drug: Enzalutamide Capsule
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting
https://ift.tt/2GCkdt5